Myelodysplastic syndrome physical examination: Difference between revisions
Jump to navigation
Jump to search
Nawal Muazam (talk | contribs) No edit summary |
|||
| (7 intermediate revisions by 2 users not shown) | |||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}}{{NM}} | {{CMG}}; {{AE}}{{NM}} | ||
==Overview== | ==Overview== | ||
Common physical examination findings of myelodysplastic syndrome include | Common physical examination findings of myelodysplastic syndrome include [[pallor]], [[hepatomegaly]], [[splenomegaly]], [[lymphadenopathy]], [[fever]], [[petechiae]], and [[purpura]].<ref name="cancergov4">Clinical features of myelodysplastic syndromes. National Cancer Institute (2015). http://www.cancer.gov/types/myeloproliferative/patient/myelodysplastic-treatment-pdq. Accessed on December 13, 2015</ref><ref name="MutluAkca2011">{{cite journal|last1=Mutlu|first1=Hasan|last2=Akca|first2=Zeki|last3=Uskudar Teke|first3=Havva|last4=Ugur|first4=Hediye|title=Evaluation of Peripheral Blood Smear for Myelodysplasia in Breast Cancer Patients who Received Adjuvant Antracycline|journal=The Eurasian Journal of Medicine|volume=42|issue=3|year=2011|pages=173–176|issn=13088734|doi=10.5152/eajm.2011.36}}</ref> | ||
==Physical Examination== | ==Physical Examination== | ||
Common physical examination findings of myelodysplastic syndrome include:<ref name=cancergov4>Clinical features of myelodysplastic syndromes. National Cancer Institute (2015). http://www.cancer.gov/types/myeloproliferative/patient/myelodysplastic-treatment-pdq. Accessed on December 13, 2015</ref> | Common physical examination findings of myelodysplastic syndrome include:<ref name="cancergov4">Clinical features of myelodysplastic syndromes. National Cancer Institute (2015). http://www.cancer.gov/types/myeloproliferative/patient/myelodysplastic-treatment-pdq. Accessed on December 13, 2015</ref><ref name="MutluAkca2011">{{cite journal|last1=Mutlu|first1=Hasan|last2=Akca|first2=Zeki|last3=Uskudar Teke|first3=Havva|last4=Ugur|first4=Hediye|title=Evaluation of Peripheral Blood Smear for Myelodysplasia in Breast Cancer Patients who Received Adjuvant Antracycline|journal=The Eurasian Journal of Medicine|volume=42|issue=3|year=2011|pages=173–176|issn=13088734|doi=10.5152/eajm.2011.36}}</ref> | ||
* | === Vital Signs === | ||
* | *[[Fever]] | ||
=== '''Skin''' === | |||
*[[Pallor]] | |||
*Diffuse erythematous rash | *Diffuse erythematous rash | ||
*[[Petechiae]] | |||
*[[Purpura]] | |||
=== Neck === | |||
*[[Lymphadenopathy]] | |||
=== Abdomen === | |||
*[[Hepatomegaly]] | |||
*[[Splenomegaly]] | |||
==References== | ==References== | ||
{{Reflist| | {{Reflist|2}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
| Line 21: | Line 37: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Neurology]] | |||
[[Category:Neurosurgery]] | |||
Latest revision as of 13:23, 29 November 2018
|
Myelodysplastic syndrome Microchapters |
|
Differentiating Myelodysplastic syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Myelodysplastic syndrome physical examination On the Web |
|
American Roentgen Ray Society Images of Myelodysplastic syndrome physical examination |
|
Risk calculators and risk factors for Myelodysplastic syndrome physical examination |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nawal Muazam M.D.[2]
Overview
Common physical examination findings of myelodysplastic syndrome include pallor, hepatomegaly, splenomegaly, lymphadenopathy, fever, petechiae, and purpura.[1][2]
Physical Examination
Common physical examination findings of myelodysplastic syndrome include:[1][2]
Vital Signs
Skin
Neck
Abdomen
References
- ↑ 1.0 1.1 Clinical features of myelodysplastic syndromes. National Cancer Institute (2015). http://www.cancer.gov/types/myeloproliferative/patient/myelodysplastic-treatment-pdq. Accessed on December 13, 2015
- ↑ 2.0 2.1 Mutlu, Hasan; Akca, Zeki; Uskudar Teke, Havva; Ugur, Hediye (2011). "Evaluation of Peripheral Blood Smear for Myelodysplasia in Breast Cancer Patients who Received Adjuvant Antracycline". The Eurasian Journal of Medicine. 42 (3): 173–176. doi:10.5152/eajm.2011.36. ISSN 1308-8734.